Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/97365
Title: | Low prevalence of Cfr-mediated linezolid resistance among methicillin-resistant Staphylococcus aureus in a Spanish hospital: case report on linezolid resistance acquired during linezolid therapy |
Author: | Sierra, Josep M. Camoez, Mariana Tubau, Fe Gasch, Oriol Pujol Rojo, Miquel Martín, Rogelio Domínguez Luzón, Ma. Ángeles (María Ángeles) |
Keywords: | Staphylococcus aureus Unitats de cures intensives Infeccions respiratòries Staphylococcus aureus Intensive care units Respiratory infections |
Issue Date: | 2013 |
Publisher: | Public Library of Science (PLoS) |
Abstract: | Linezolid is an effective antimicrobial agent to treat methicillin-resistant Staphylococcus aureus (MRSA). Resistance to linezolid due to the cfr gene is described worldwide. The present study aimed to analyze the prevalence of the cfr-mediated linezolid resistance among MRSA clinical isolates in our area. A very low prevalence of cfr mediated linezolid resistance was found: only one bacteremic isolate out of 2 215 screened isolates. The only linezolid resistant isolate arose in a patient, previously colonized by MRSA, following linezolid therapy. Despite the low rate of resistance in our area, ongoing surveillance is advisable to avoid the spread of linezolid resistance. |
Note: | Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0059215 |
It is part of: | PLoS One, 2013, vol. 8, num. 3 |
URI: | http://hdl.handle.net/2445/97365 |
Related resource: | http://dx.doi.org/10.1371/journal.pone.0059215 |
ISSN: | 1932-6203 |
Appears in Collections: | Articles publicats en revistes (Patologia i Terapèutica Experimental) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
638652.pdf | 123.44 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License